Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Distilled Law, Part 1: Whisky Business: Alberta's New Spirit Standards And The Future Of AI Use In Legislative Drafting
The Government of Alberta has reportedly become the first jurisdiction in Canada to use artificial intelligence (“AI”) in the initial drafting of the Alberta Whisky Act (the “Whisky Act”). The Whisky Act, which came into effect on May 21, 2026, establishes new standards and definitions for what qualifies as “Alberta Whisky”, including requirements relating to production standards, ingredients, and processes. According to the province, AI was used as part of the drafting process, with government officials and legislative counsel retaining responsibility for review, revision, and all levels of approval.
Canada Healthcare
F
Fasken
Article
More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules
A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
Canada Healthcare
F
Fasken
Article
Santé Canada Lance Un Portail De Recherche Des Essais Cliniques Et Des Lignes Directrices Sur L’enregistrement Et La Divulgation Des Résultats
Le 29 juillet 2026, Santé Canada a lancé un nouveau portail de recherche pour les essais cliniques et publié sa ligne directrice sur l’enregistrement des essais cliniques et la divulgation publique des résultats afin de donner au public un meilleur accès aux renseignements sur les essais cliniques autorisés au Canada.
Canada Healthcare
FF
Fasken (French)
See more

Webinars

See More

Food and Drugs Law

Article
Do Canadian Manufacturers Owe A Duty To Develop Safer Alternatives?
The British Columbia Court of Appeal has left open the possibility that pharmaceutical manufacturers may owe a duty of care to develop safer alternatives to their existing products, even when those products are properly approved and labeled. This decision in Gilead Sciences, Inc. v. I.F. contrasts sharply with a recent California Supreme Court ruling that rejected such a "duty to innovate," potentially setting Canada on a divergent path in product liability law.
Canada Litigation
TL
Torys LLP
Article
Peptides In Canada: Regulatory Reality Is Catching Up With The Hype
Health Canada's recent enforcement action against unauthorized injectable peptides signals a regulatory shift that wellness companies cannot afford to ignore. While peptides dominate influencer marketing and online wellness spaces, their legal status in Canada depends on factors far more complex than social media trends suggest. Understanding how route of administration, therapeutic claims, and market authorization intersect is now critical for compliance.
Canada Consumer
GW
Gowling WLG
Article
Distilled Law, Part 1: Whisky Business: Alberta's New Spirit Standards And The Future Of AI Use In Legislative Drafting
The Government of Alberta has reportedly become the first jurisdiction in Canada to use artificial intelligence (“AI”) in the initial drafting of the Alberta Whisky Act (the “Whisky Act”). The Whisky Act, which came into effect on May 21, 2026, establishes new standards and definitions for what qualifies as “Alberta Whisky”, including requirements relating to production standards, ingredients, and processes. According to the province, AI was used as part of the drafting process, with government officials and legislative counsel retaining responsibility for review, revision, and all levels of approval.
Canada Healthcare
F
Fasken
See more

Healthcare

Article
More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules
A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
Canada Healthcare
F
Fasken
Article
Santé Canada Lance Un Portail De Recherche Des Essais Cliniques Et Des Lignes Directrices Sur L’enregistrement Et La Divulgation Des Résultats
Le 29 juillet 2026, Santé Canada a lancé un nouveau portail de recherche pour les essais cliniques et publié sa ligne directrice sur l’enregistrement des essais cliniques et la divulgation publique des résultats afin de donner au public un meilleur accès aux renseignements sur les essais cliniques autorisés au Canada.
Canada Healthcare
FF
Fasken (French)
See more

Life Sciences, Biotechnology & Nanotechnology

Article
More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules
A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
Canada Healthcare
F
Fasken
Article
Santé Canada Lance Un Portail De Recherche Des Essais Cliniques Et Des Lignes Directrices Sur L’enregistrement Et La Divulgation Des Résultats
Le 29 juillet 2026, Santé Canada a lancé un nouveau portail de recherche pour les essais cliniques et publié sa ligne directrice sur l’enregistrement des essais cliniques et la divulgation publique des résultats afin de donner au public un meilleur accès aux renseignements sur les essais cliniques autorisés au Canada.
Canada Healthcare
FF
Fasken (French)
See more

Latest Videos

See more